Merck and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry
Merck opens first climate-neutral manufacturing facility in Ireland
Biocytogen will provide proprietary, fully human antibodies derived from its RenMice platform for evaluation in Merck’s antibody-conjugated LNP services
He has successfully led the development of 15 approved drugs worldwide across various therapeutic areas over his more than 20-year career
Protein L is known as a “superantigen” because it can bind antibodies in unusual ways
Skyhawk Therapeutics enters into an option agreement to grant Merck KGaA, Darmstadt, Germany, exclusive global rights to drug candidates pursued under the collaboration upon option exercise
Projects 5X revenue growth by 2028, accelerates global market leadership and paves the way for IPO
Merck and mantro GmbH have established EdiMembre, Massachusetts, U.S.A., a Deep Tech spin-out in the alternative protein industry
OGSIVEO is the first and only therapy to receive marketing authorization in the EU for the treatment of desmoid tumors
The coating is designed for heat-sealable applications, offering oil and grease resistance on kraft paper and suitable blister coatings for paper and paperboard
Subscribe To Our Newsletter & Stay Updated
